Our previous work explored the benefit of active versus passive lifestyle modification in nondiabetic kidney transplant recipients in the CAVIAR randomized controlled trial.1 It introduced the concept of incorporating evidence-based behavior change therapy (BCT) into posttransplant care. While failing to show any benefit in the primary outcome of glycemic pathophysiology, it demonstrated improvements in secondary outcomes including weight and fat mass, and a trend toward less posttransplantation diabetes mellitus (PTDM; 7.6% vs 15.6%) for active versus passive intervention arms, respectively, after a 6-month personalized intervention.